These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 17517063)

  • 121. Interaction of arginine-rich peptides with membrane-associated proteoglycans is crucial for induction of actin organization and macropinocytosis.
    Nakase I; Tadokoro A; Kawabata N; Takeuchi T; Katoh H; Hiramoto K; Negishi M; Nomizu M; Sugiura Y; Futaki S
    Biochemistry; 2007 Jan; 46(2):492-501. PubMed ID: 17209559
    [TBL] [Abstract][Full Text] [Related]  

  • 122. Lipoprotein lipase S447X: a naturally occurring gain-of-function mutation.
    Rip J; Nierman MC; Ross CJ; Jukema JW; Hayden MR; Kastelein JJ; Stroes ES; Kuivenhoven JA
    Arterioscler Thromb Vasc Biol; 2006 Jun; 26(6):1236-45. PubMed ID: 16574898
    [TBL] [Abstract][Full Text] [Related]  

  • 123. Binding and intracellular trafficking of lipoprotein lipase and triacylglycerol-rich lipoproteins by liver cells.
    Casaroli-Marano RP; García R; Vilella E; Olivecrona G; Reina M; Vilaró S
    J Lipid Res; 1998 Apr; 39(4):789-806. PubMed ID: 9555944
    [TBL] [Abstract][Full Text] [Related]  

  • 124. Hepatitis C Virus Entry into Macrophages/Monocytes Mainly Depends on the Phagocytosis of Macrophages.
    Liu Y; Wang W; Zou Z; Hu Z; Fan Q; Xiong J
    Dig Dis Sci; 2019 May; 64(5):1226-1237. PubMed ID: 30535782
    [TBL] [Abstract][Full Text] [Related]  

  • 125. Heparan sulfate proteoglycans and triglyceride-rich lipoprotein metabolism.
    Bishop JR; Stanford KI; Esko JD
    Curr Opin Lipidol; 2008 Jun; 19(3):307-13. PubMed ID: 18460924
    [TBL] [Abstract][Full Text] [Related]  

  • 126. Hepatitis C virus-apolipoprotein interactions: molecular mechanisms and clinical impact.
    Crouchet E; Baumert TF; Schuster C
    Expert Rev Proteomics; 2017 Jul; 14(7):593-606. PubMed ID: 28625086
    [TBL] [Abstract][Full Text] [Related]  

  • 127. Binding of liver derived, low density hepatitis C virus to human hepatoma cells.
    Martin C; Nielsen SU; Ibrahim S; Bassendine MF; Toms GL
    J Med Virol; 2008 May; 80(5):816-23. PubMed ID: 18360895
    [TBL] [Abstract][Full Text] [Related]  

  • 128. Apolipoprotein(a) inhibits hepatitis C virus entry through interaction with infectious particles.
    Oliveira C; Fournier C; Descamps V; Morel V; Scipione CA; Romagnuolo R; Koschinsky ML; Boullier A; Marcelo P; Domon JM; Brochot E; Duverlie G; Francois C; Castelain S; Helle F
    Hepatology; 2017 Jun; 65(6):1851-1864. PubMed ID: 28152568
    [TBL] [Abstract][Full Text] [Related]  

  • 129. Hepatitis C virus host cell entry.
    Ploss A; Evans MJ
    Curr Opin Virol; 2012 Feb; 2(1):14-9. PubMed ID: 22440961
    [TBL] [Abstract][Full Text] [Related]  

  • 130. Interplay among cellular polarization, lipoprotein metabolism and hepatitis C virus entry.
    Benedicto I; Molina-Jiménez F; Moreno-Otero R; López-Cabrera M; Majano PL
    World J Gastroenterol; 2011 Jun; 17(22):2683-90. PubMed ID: 21734774
    [TBL] [Abstract][Full Text] [Related]  

  • 131. Analysis of Hepatitis C Virus Particle Heterogeneity in Immunodeficient Human Liver Chimeric
    Andreo U; de Jong YP; Scull MA; Xiao JW; Vercauteren K; Quirk C; Mommersteeg MC; Bergaya S; Menon A; Fisher EA; Rice CM
    Cell Mol Gastroenterol Hepatol; 2017 Nov; 4(3):405-417. PubMed ID: 28936471
    [TBL] [Abstract][Full Text] [Related]  

  • 132. Antipeptide antibodies reveal interrelationships of MBP 200 and MBP 235: unique apoB-specific receptors for triglyceride-rich lipoproteins on human monocyte-macrophages.
    Bradley WA; Brown ML; Ramprasad MP; Li R; Song R; Gianturco SH
    J Lipid Res; 1999 Apr; 40(4):744-52. PubMed ID: 10191299
    [TBL] [Abstract][Full Text] [Related]  

  • 133. Roles of lipoprotein receptors in the entry of hepatitis C virus.
    Lyu J; Imachi H; Fukunaga K; Yoshimoto T; Zhang H; Murao K
    World J Hepatol; 2015 Oct; 7(24):2535-42. PubMed ID: 26527170
    [TBL] [Abstract][Full Text] [Related]  

  • 134. The rate of hepatitis C virus infection initiation in vitro is directly related to particle density.
    Sabahi A; Marsh KA; Dahari H; Corcoran P; Lamora JM; Yu X; Garry RF; Uprichard SL
    Virology; 2010 Nov; 407(1):110-9. PubMed ID: 20800257
    [TBL] [Abstract][Full Text] [Related]  

  • 135. Recent advances in hepatitis C virus cell entry.
    Bartosch B; Dubuisson J
    Viruses; 2010 Mar; 2(3):692-709. PubMed ID: 21994653
    [TBL] [Abstract][Full Text] [Related]  

  • 136. Progress with hepatitis C.
    Griffiths P
    Rev Med Virol; 2006; 16(4):205-7. PubMed ID: 16823762
    [No Abstract]   [Full Text] [Related]  

  • 137. Myosin 9 and N-glycans jointly regulate human papillomavirus entry.
    Zhang Y; Liu W; He F; Liu YJ; Jiang H; Hao C; Wang W
    J Biol Chem; 2024 Feb; 300(2):105660. PubMed ID: 38242322
    [TBL] [Abstract][Full Text] [Related]  

  • 138. [In vitro hepatitis C. Elimination of lipoproteins associated with cells: an important stage to obtain an efficient infection of human hepatocytes by the hepatitis C virus].
    Favre D; Berthillon P; Trépo C
    Rev Med Suisse Romande; 2002 Apr; 122(4):205. PubMed ID: 12071140
    [No Abstract]   [Full Text] [Related]  

  • 139. SMAD About Hepatitis C Virus Cell Entry and Liver Disease.
    Colpitts CC; Baumert TF
    Gastroenterology; 2017 Jan; 152(1):21-23. PubMed ID: 27889572
    [No Abstract]   [Full Text] [Related]  

  • 140. Cellular assays for lipoprotein receptors.
    Acton S; Rigotti A
    Methods Mol Biol; 1998; 110():253-66. PubMed ID: 9918052
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.